![John Leaman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Leaman
Direktor/Vorstandsmitglied bei
TRAWS PHARMA, INC.
Vermögen: 5 925 $ am 31.05.2026
Profil
John Harold Leaman is currently an Independent Director at Traws Pharma, Inc. since 2025 and Chief Financial Officer at Cellarity Inc. Formerly, Dr. Leaman was Head-Corporate Development at InfaCare Pharmaceutical Corp.
in 2017, Secretary, Chief Financial & Business Officer at IPI Legacy Liquidation Co. from 2019 to 2023, Chief Financial Officer & Head-Corporate Strategy at Selecta Biosciences, Inc. from 2017 to 2019, Associate Principal at McKinsey & Co., Inc., Chief Financial Officer at Aevi Genomic Medicine, Inc. from 2014 to 2016, and Principal at Devon Park Bioventures.
Education includes undergraduate degrees from Elizabethtown College and Oriel College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from Perelman School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TRAWS PHARMA, INC. 0.03% | 08.03.2026 | 4’058 ( 0.03% ) | 5 925 $ | 31.05.2026 |
Aktive Positionen von John Leaman
| Unternehmen | Position | Beginn |
|---|---|---|
| TRAWS PHARMA, INC. | Direktor/Vorstandsmitglied | 01.10.2025 |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von John Leaman
| Unternehmen | Position | Ende |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Finanzdirektor/CFO | 10.03.2023 |
| CARTESIAN THERAPEUTICS, INC. | Finanzdirektor/CFO | 31.03.2019 |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology Develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population | Corporate Officer/Principal | 01.09.2017 |
| AEVI GENOMIC MEDICINE, INC. | Finanzdirektor/CFO | 09.02.2016 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Ausbildung von John Leaman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Traws Pharma, Inc.
 Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology Develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Elizabethtown College
 Elizabethtown College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
Devon Park Bioventures
 Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Oriel College
 Oriel College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
